THIS CONSULTING AGREEMENT (the “ Agreement ”), dated as of June 15, 2010, (the “ Effective Date ”), is by and between
Pro-Pharmaceuticals, Inc., a Nevada corporation, with a principal place of business at 7 Wells Avenue, Newton, MA 02459 and
its successors, subsidiaries and affiliates (collectively, the “ Company ”), and PGT BioMedical Consulting, LLC, with a principal
place of business at 828 Flamingo Rd, #207, Las Vegas, NV, 89119, (“ Consultant ”).
W I T N E S S E T H
WHEREAS, the Company desires to have the benefit of Consultant’s knowledge and experience, and Consultant desires
to provide consulting and advisory services to the Company, all as hereinafter provided in this Agreement;
NOW, THEREFORE, in consideration of the foregoing premises and mutual agreements hereinafter set forth, the Company
and Consultant hereby agree as follows:
3.1 During the Consultation Period, Consultant shall render to Company or to Company’s designee such consulting
and advisory services in its areas of expertise and knowledge related to the role of Chief Medical Officer and all
associated responsibilities as outlined in Appendix 1.
3.2 Consultant agrees to provide the necessary effort to accomplish mutually agreed tasks. All work to be performed
by Consultant for the Company shall be under the general supervision of the Company. The Consultant will:
3.3 Complete a “Strategic Plan” for Drug Development and Approval, with the objective of gaining multiple approvals
for DAVANAT in the field of oncology.
3.4 Complete a “Strategic Plan” for the Development and Approval of a drug for liver fibrosis/cirrhosis with the
objective of entering into a partnership to run and fund for the human clinical trials.
Consultation . The Company shall retain Consultant as a non-exclusive consultant and advisor, and Consultant shall
serve the Company as a consultant and advisor upon the terms and conditions hereinafter set forth. The Consultant
agrees that Dr. Traber